Pakistan
· Delayed Price · Currency is PKR IBL HealthCare Statistics
Total Valuation
IBL HealthCare has a market cap or net worth of PKR 5.12 billion. The enterprise value is 5.48 billion.
| Market Cap | 5.12B |
| Enterprise Value | 5.48B |
Important Dates
The next estimated earnings date is Friday, October 3, 2025.
| Earnings Date | Oct 3, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IBL HealthCare has 85.67 million shares outstanding. The number of shares has decreased by -0.28% in one year.
| Current Share Class | 85.67M |
| Shares Outstanding | 85.67M |
| Shares Change (YoY) | -0.28% |
| Shares Change (QoQ) | +0.91% |
| Owned by Insiders (%) | 1.16% |
| Owned by Institutions (%) | 4.42% |
| Float | 21.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.44 |
| PB Ratio | 2.27 |
| P/TBV Ratio | 2.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 38.89, with an EV/FCF ratio of -25.80.
| EV / Earnings | -140.62 |
| EV / Sales | 1.54 |
| EV / EBITDA | 38.89 |
| EV / EBIT | 40.37 |
| EV / FCF | -25.80 |
Financial Position
The company has a current ratio of 2.17, with a Debt / Equity ratio of 0.17.
| Current Ratio | 2.17 |
| Quick Ratio | 1.29 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | 2.78 |
| Debt / FCF | -1.84 |
| Interest Coverage | 2.26 |
Financial Efficiency
Return on equity (ROE) is -1.72% and return on invested capital (ROIC) is 3.29%.
| Return on Equity (ROE) | -1.72% |
| Return on Assets (ROA) | 2.35% |
| Return on Invested Capital (ROIC) | 3.29% |
| Return on Capital Employed (ROCE) | 5.98% |
| Revenue Per Employee | 12.21M |
| Profits Per Employee | -133,414 |
| Employee Count | 292 |
| Asset Turnover | 0.99 |
| Inventory Turnover | 2.83 |
Taxes
In the past 12 months, IBL HealthCare has paid 100.96 million in taxes.
| Income Tax | 100.96M |
| Effective Tax Rate | 162.83% |
Stock Price Statistics
The stock price has increased by +79.34% in the last 52 weeks. The beta is 0.76, so IBL HealthCare's price volatility has been lower than the market average.
| Beta (5Y) | 0.76 |
| 52-Week Price Change | +79.34% |
| 50-Day Moving Average | 43.44 |
| 200-Day Moving Average | 38.45 |
| Relative Strength Index (RSI) | 68.15 |
| Average Volume (20 Days) | 3,569,176 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IBL HealthCare had revenue of PKR 3.57 billion and -38.96 million in losses. Loss per share was -0.46.
| Revenue | 3.57B |
| Gross Profit | 830.57M |
| Operating Income | 135.70M |
| Pretax Income | 62.01M |
| Net Income | -38.96M |
| EBITDA | 137.97M |
| EBIT | 135.70M |
| Loss Per Share | -0.46 |
Balance Sheet
The company has 31.04 million in cash and 391.12 million in debt, giving a net cash position of -360.09 million or -4.20 per share.
| Cash & Cash Equivalents | 31.04M |
| Total Debt | 391.12M |
| Net Cash | -360.09M |
| Net Cash Per Share | -4.20 |
| Equity (Book Value) | 2.25B |
| Book Value Per Share | 26.26 |
| Working Capital | 1.62B |
Cash Flow
In the last 12 months, operating cash flow was -194.03 million and capital expenditures -18.34 million, giving a free cash flow of -212.36 million.
| Operating Cash Flow | -194.03M |
| Capital Expenditures | -18.34M |
| Free Cash Flow | -212.36M |
| FCF Per Share | -2.48 |
Margins
Gross margin is 23.29%, with operating and profit margins of 3.81% and -1.09%.
| Gross Margin | 23.29% |
| Operating Margin | 3.81% |
| Pretax Margin | 1.74% |
| Profit Margin | -1.09% |
| EBITDA Margin | 3.87% |
| EBIT Margin | 3.81% |
| FCF Margin | n/a |
Dividends & Yields
IBL HealthCare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.28% |
| Shareholder Yield | n/a |
| Earnings Yield | -0.76% |
| FCF Yield | -4.15% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 19, 2023. It was a forward split with a ratio of 1.2.
| Last Split Date | Oct 19, 2023 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
IBL HealthCare has an Altman Z-Score of 3.39 and a Piotroski F-Score of 1.
| Altman Z-Score | 3.39 |
| Piotroski F-Score | 1 |